1. What Pharmaceutical Sales Data Actually Measures Pharmaceutical sales data is not a single dataset. It is a composite of […]
Drug Sales Data: The Complete Playbook for Channel Strategy and Portfolio Dominance Read Post »
How to use price erosion curves, Paragraph IV filings, Orange Book patent analysis, and biosimilar IP valuation to build a
Generic Entry Pricing: The Complete Drug Price Data Playbook for Portfolio Managers Read Post »
Information contained in expired drug patents can be invaluable to researchers developing new products, but caution is required to avoid legal problems.
The global generic drugs market was valued at $468.08 billion in 2025 and is projected to reach $728.64 billion by
The Economic Imperative of Time In the pharmaceutical sector, time is a tangible asset with a valuation that often exceeds
A strategic guide to patent expiry, lifecycle defense, and the economics of generic competition — for executives, investors, and analysts
What Happens When a Drug Patent Expires? Understanding Drug Patent Life Read Post »
Every year, dozens of brand-name drugs approach the end of their patent life with billions in annual revenue at stake.
Tentative Drug Approvals: The Definitive Generic Entry Forecasting Playbook Read Post »
Executive Summary Pfizer’s management of sildenafil citrate’s loss of exclusivity (LOE) in the United States is the closest thing small-molecule
Viagra’s Generic Cliff: Why It Wasn’t a Free-for-All Read Post »
Drugs can have many patents and regulatory protections Drugs can be covered by myriad patents and regulatory protections. Even Aspirin,
Get fresh news and insights, drug patent expirations & more…
